Public Consultation: DRAFT 2025 Clinical Guidelines for the Early Detection of Prostate Cancer

USANZ Members are invited to submit feedback on the Prostate Cancer Foundation of Australia (PCFA) DRAFT 2025 Clinical Guidelines for the Early Detection of Prostate Cancer.

PCFA is seeking approval under section 14A of the National Health and Medical Research Council Act 1992 for the DRAFT 2025 Guidelines. As part of the approval process, Australian stakeholders are invited to submit feedback.

The DRAFT 2025 Guidelines are designed to supersede the 2016 Clinical Practice Guidelines for PSA Testing, recognising that significant advancements in diagnosis and treatment have created an evidence-based pathway for a more structured testing program.

For more information on the public consultation, including all consultation material, visit the PCFA website.

Consultation on the DRAFT 2025 Guidelines are now open and will closed on Sunday 25 May 2025. Submissions can be made via an online form.